Also from this source

You just read:

The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Pancreatic Cancer Treatment

News provided by

Yisheng Biopharma Co., Ltd.

Feb 26, 2018, 09:00 EST